Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Gynecologic oncology"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22PARP%22&type=Subject&filter%5B%5D=journalStr%3A%22Gynecologic+oncology%22
/vufind/Search/Results?lookfor=%22PARP%22&type=Subject&filter%5B%5D=journalStr%3A%22Gynecologic+oncology%22
Search /vufind/Search2/Results?lookfor=%22PARP%22&type=Subject&filter%5B%5D=journalStr%3A%22Gynecologic+oncology%22
PubPharm (80)
1
"Having cancer is very expensive" : A qualitative study of patients with ovarian cancer and PARP inhibitor treatment
enthalten in:
Gynecologic oncology
| 2024
von
Smith, A.
|
O'Brien, C.
|
Haggerty, A.
| +2
Wird geladen...
2
Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistance
enthalten in:
Gynecologic oncology
| 2024
von
Levine, M.
|
Wang, H.
|
Sriram, B.
| +11
Wird geladen...
3
Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer
enthalten in:
Gynecologic oncology
| 2024
von
Kim, J.
|
Kim, S.
|
Park, E.
| +5
Wird geladen...
4
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo : Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial
enthalten in:
Gynecologic oncology
| 2024
von
Pothuri, B.
|
Han, S.
|
Chase, D.
| +23
Wird geladen...
5
Health care services utilization in patients with ovarian cancer receiving PARP inhibitor maintenance treatment in a US community oncology setting
enthalten in:
Gynecologic oncology
| 2024
von
Chase, D.
|
Annavarapu, S.
|
Tseng, W.
| +3
Wird geladen...
6
Pilot randomized trial of an acceptance-based telehealth intervention for women with ovarian cancer and PARP inhibitor-related fatigue
enthalten in:
Gynecologic oncology
| 2023
von
Wright, A.
|
Poort, H.
|
Tavormina, A.
| +9
Wird geladen...
7
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma : Results of a Delphi study
enthalten in:
Gynecologic oncology
| 2023
von
Colombo, N.
|
Gadducci, A.
|
Landoni, F.
| +25
Wird geladen...
8
Patient-reported outcomes of maintenance rucaparib in patients with recurrent ovarian carcinoma in ARIEL3, a phase III, randomized, placebo-controlled trial
enthalten in:
Gynecologic oncology
| 2023
von
Peipert, J.
|
Goble, S.
|
Isaacson, J.
| +5
Wird geladen...
9
PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients
enthalten in:
Gynecologic oncology
| 2023
von
Gauduchon, T.
|
Kfoury, M.
|
Lorusso, D.
| +17
Wird geladen...
10
The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitro and in vivo
enthalten in:
Gynecologic oncology
| 2023
von
Han, C.
|
McNamara, B.
|
Bellone, S.
| +17
Wird geladen...
1
2
3
4
5
6
7
8
Nächster »
[8]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Gynecologic oncology
Medienart
80
Aufsätze
77
E-Artikel
77
E-Ressourcen
3
Gedruckte Aufsätze
Zeitschriftentitel
Gynecologic oncology
Thema
76
Journal Article
50
Poly(ADP-ribose) Polymerase Inhibitors
49
Ovarian cancer
40
Research Support, Non-U.S. Gov't
32
PARP inhibitor
26
PARP inhibitors
22
Research Support, N.I.H., Extramural
19
Phthalazines
19
WOH1JD9AR8
19
olaparib
18
BRCA1 Protein
18
BRCA1 protein, human
18
Piperazines
13
EC 2.4.2.30
13
Multicenter Study
13
Poly (ADP-Ribose) Polymerase-1
12
Antineoplastic Agents
12
BRCA2 Protein
12
BRCA2 protein, human
12
Olaparib
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
44
2020-
33
2010-2019
3
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
80
Englisch
Haven't found what you're looking for?
Wird geladen...